SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michelle Martinot-Peignoux, Patrick Marcellin, Virological and serological tools to optimize the management of patients with chronic hepatitis B, Liver International, 2016, 36,
  2. 2
    Yin Xu, Peng Huang, Ming Yue, Jing Su, Hongbo Chen, Mingzhu Chen, Jie Wang, Jun Li, Zhihang Peng, Yun Zhang, Rongbin Yu, A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients, Journal of Human Genetics, 2015,

    CrossRef

  3. 3
    Paul Martin, Daryl T.-Y. Lau, Mindie H. Nguyen, Harry L.A. Janssen, Douglas T. Dieterich, Marion G. Peters, Ira M. Jacobson, A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update, Clinical Gastroenterology and Hepatology, 2015, 13, 12, 2071

    CrossRef

  4. 4
    G. V. Papatheodoridis, S. Manolakopoulos, G. Touloumi, G. Nikolopoulou, M. Raptopoulou-Gigi, C. Gogos, I. Vafiadis-Zouboulis, D. Karamanolis, A. Chouta, A. Ilias, C. Drakoulis, K. Mimidis, I. Ketikoglou, E. Manesis, M. Mela, G. Hatzis, G. N. Dalekos, Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort, Journal of Viral Hepatitis, 2015, 22, 2
  5. 5
    Marta Spreafico, Alessandra Berzuini, Barbara Foglieni, Daniel Candotti, Livia Raffaele, Irene Guarnori, Agostino Colli, Francesco Fumagalli Maldini, Jean-Pierre Allain, Daniele Prati, Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy, Journal of Hepatology, 2015, 63, 5, 1068

    CrossRef

  6. 6
    Pia L. Seiz, Heiko Slanina, John Ziebuhr, Wolfram H. Gerlich, Dieter Glebe, Christian G. Schüttler, Studies of nosocomial outbreaks of hepatitis B in nursing homes in Germany suggest a major role of hepatitis B e antigen expression in disease severity and progression, International Journal of Medical Microbiology, 2015, 305, 7, 663

    CrossRef

  7. 7
    Wei Wang, Hongpin Liang, Yongbin Zeng, Jinpiao Lin, Can Liu, Ling Jiang, Bin Yang, Qishui Ou, Establishment of a novel two-probe real-time PCR for simultaneously quantification of hepatitis B virus DNA and distinguishing genotype B from non-B genotypes, Clinica Chimica Acta, 2014, 437, 168

    CrossRef

  8. 8
    S. Davison, Management of chronic hepatitis B infection, Archives of Disease in Childhood, 2014, 99, 11, 1037

    CrossRef

  9. 9
    Young–Suk Lim, Seungbong Han, Nae–Yun Heo, Ju Hyun Shim, Han Chu Lee, Dong Jin Suh, Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine, Gastroenterology, 2014, 147, 1, 152

    CrossRef

  10. 10
    C. S. Coffin, M. Rezaeeaval, J. X. Pang, L. Alcantara, P. Klein, K. W. Burak, R. P. Myers, The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy, Alimentary Pharmacology & Therapeutics, 2014, 40, 11-12
  11. 11
    Marta Melis, Giacomo Diaz, David E Kleiner, Fausto Zamboni, Juraj Kabat, Jinping Lai, Giulia Mogavero, Ashley Tice, Ronald E Engle, Steven Becker, Charles R Brown, Jeffrey C Hanson, Jaime Rodriguez-Canales, Michael Emmert-Buck, Sugantha Govindarajan, Michael Kew, Patrizia Farci, Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus - associated hepatocellular carcinoma, Journal of Translational Medicine, 2014, 12, 1

    CrossRef

  12. 12
    Lunan Wang, Yang Pan, Kuo Zhang, Rui Zhang, Yu Sun, Jiehong Xie, Jinming Li, A 10-year human hepatitis B virus nucleic test external quality assessment in China: continual improvement, Clinica Chimica Acta, 2013, 425, 139

    CrossRef

  13. 13
    Wolfram H Gerlich, Medical Virology of Hepatitis B: how it began and where we are now, Virology Journal, 2013, 10, 1, 239

    CrossRef

  14. 14
    S. A. Baylis, L. Ma, D. J. Padley, A. B. Heath, M. W. Yu, Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays, Vox Sanguinis, 2012, 102, 3
  15. 15
    EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection, Journal of Hepatology, 2012, 57, 1, 167

    CrossRef

  16. 16
    In Sung Kim, Jun Il Mun, Jee Hoon Koo, Chang Jun Kang, Jean Kyung Bak, Jae Yoeun Cheong, Sung Won Cho, Entecavir Therapy for Patients with Hepatitis B Virus-related Decompensated Cirrhosis, The Korean Journal of Gastroenterology, 2012, 59, 3, 224

    CrossRef

  17. 17
    M. Chudy, K.-M. Hanschmann, J. Kress, S. Nick, R. Campos, U. Wend, W. Gerlich, C.M. Nübling, First WHO International Reference Panel containing hepatitis B virus genotypes A–G for assays of the viral DNA, Journal of Clinical Virology, 2012, 55, 4, 303

    CrossRef

  18. 18
    Marion Vermeulen, Caroline Dickens, Nico Lelie, Evangelia Walker, Charl Coleman, Mark Keyter, Ravi Reddy, Robert Crookes, Anna Kramvis, Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk, Transfusion, 2012, 52, 4
  19. 19
    D. Robert Dufour, Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 2012,

    CrossRef

  20. 20
    Thomas E. Grys, Developing a Quality System for Quantitative Laboratory-Developed Tests, Clinical Microbiology Newsletter, 2011, 33, 23, 179

    CrossRef

  21. 21
    Zhejun Cai, Guoqiang Lou, Ting Cai, Jin Yang, Nanping Wu, Development of a novel genotype-specific loop-mediated isothermal amplification technique for Hepatitis B virus genotypes B and C genotyping and quantification, Journal of Clinical Virology, 2011, 52, 4, 288

    CrossRef

  22. 22
    F. M. Sanai, A. Helmy, K. I. Bzeizi, M. A. Babatin, A. Al-Qahtani, H. A. Al-Ashgar, A. S. Al-Mdani, A. Al-Akwaa, S. Almutharea, M. Q. Khan, A. S. Alghamdi, T. Farah, W. Al-Hamoudi, M. Saadeh, A. A. Abdo, Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B, Journal of Viral Hepatitis, 2011, 18, 7
  23. 23
    Marcia J Holden, Roberta M Madej, Philip Minor, Lisa V Kalman, Molecular diagnostics: harmonization through reference materials, documentary standards and proficiency testing, Expert Review of Molecular Diagnostics, 2011, 11, 7, 741

    CrossRef

  24. 24
    Si Nafa Si Ahmed, Marie Ecochard, Fabien Zoulim, End points of therapy in chronic hepatitis B, Expert Review of Gastroenterology & Hepatology, 2010, 4, 1, 37

    CrossRef

  25. 25
    James Fung, Ching-Lung Lai, Man-Fung Yuen, Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B, Expert Review of Anti-infective Therapy, 2010, 8, 6, 717

    CrossRef

  26. 26
    P. Dény, F. Zoulim, Hepatitis B virus: From diagnosis to treatment, Pathologie Biologie, 2010, 58, 4, 245

    CrossRef

  27. 27
    Roberta M. Madej, Jack Davis, Marcia J. Holden, Stan Kwang, Emmanuel Labourier, George J. Schneider, International Standards and Reference Materials for Quantitative Molecular Infectious Disease Testing, The Journal of Molecular Diagnostics, 2010, 12, 2, 133

    CrossRef

  28. 28
    F. B. Hollinger, G. Sood, Occult hepatitis B virus infection: a covert operation, Journal of Viral Hepatitis, 2010, 17, 1
  29. 29
    In Hee Kim, Seok Lee, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae Ghon Kim, Chang Soo Choi, Haak Cheoul Kim, Treatment Outcomes of Clevudine versus Lamivudine at Week 48 in Naïve Patients with HBeAg Positive Chronic Hepatitis B, Journal of Korean Medical Science, 2010, 25, 5, 738

    CrossRef

  30. 30
    ERIC C. JOHANNSEN, KENNETH M. KAYE, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  31. 31
    EASL Clinical Practice Guidelines: Management of chronic hepatitis B, Journal of Hepatology, 2009, 50, 2, 227

    CrossRef

  32. 32
    Sebastian Goedel, Matthias Rullkoetter, Sabrina Weisshaar, Carola Mietag, Hermann Leying, Florian Boehl, Hepatitis B virus (HBV) genotype determination by the COBAS® AmpliPrep/COBAS® TaqMan® HBV Test, v2.0 in serum and plasma matrices, Journal of Clinical Virology, 2009, 45, 3, 232

    CrossRef

  33. 33
    Corinna M. Bremer, Christiane Bung, Nicole Kott, Martin Hardt, Dieter Glebe, Hepatitis B virus infection is dependent on cholesterol in the viral envelope, Cellular Microbiology, 2009, 11, 2
  34. 34
    J. K. Preiksaitis, X. L. Pang, J. D. Fox, J. M. Fenton, A. M. Caliendo, G. G. Miller, Interlaboratory Comparison of Epstein-Barr Virus Viral Load Assays, American Journal of Transplantation, 2009, 9, 2
  35. 35
    Recommandations de pratiques cliniques de l’EASL. Prise en charge de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2009, 33, 6-7, 539

    CrossRef

  36. 36
    Corinna M. Bremer, Mona Saniewski, Ulrike C. Wend, Pilar Torres, Nico Lelie, Wolfram H. Gerlich, Dieter Glebe, Transient occult hepatitis B virus infection in a blood donor with high viremia, Transfusion, 2009, 49, 8
  37. 37
    Hie-Won Hann, Vicki L. Gregory, Jonathan S. Dixon, Keith F. Barker, A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B, Hepatology International, 2008, 2, 4, 440

    CrossRef

  38. 38
    Emmet B. Keeffe, Douglas T. Dieterich, Steven-Huy B. Han, Ira M. Jacobson, Paul Martin, Eugene R. Schiff, Hillel Tobias, A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update, Clinical Gastroenterology and Hepatology, 2008, 6, 12, 1315

    CrossRef

  39. 39
    S. A. Baylis, A. B. Heath, M. Chudy, G. Pisani, A. Klotz, S. Kerby, W. Gerlich, An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays, Vox Sanguinis, 2008, 94, 4
  40. 40
    Tin Nguyen, Stephen Locarnini, Paul Desmond, Changing landscape of antiviral resistance management in chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2008, 23, 9
  41. 41
    Ting Cai, GuoQiang Lou, Jin Yang, Dai Xu, ZhongHua Meng, Development and evaluation of real-time loop-mediated isothermal amplification for hepatitis B virus DNA quantification: A new tool for HBV management, Journal of Clinical Virology, 2008, 41, 4, 270

    CrossRef

  42. 42
    Prista Charuworn, Ramsey Cheung, Diagnostic markers for hepatitis virus infection, Expert Opinion on Medical Diagnostics, 2008, 2, 3, 303

    CrossRef

  43. 43
    G. Pisani, F. Marino, K. Cristiano, G. M. Bisso, C. Mele, F. Luciani, M. Wirz, G. Gentili, External quality assessment for the detection of HCV RNA, HIV RNA and HBV DNA in plasma by nucleic acid amplification technology: a novel approach, Vox Sanguinis, 2008, 95, 1
  44. 44
    C. Osiowy, D. Gordon, J. Borlang, E. Giles, J.-P. Villeneuve, Hepatitis B virus genotype G epidemiology and co-infection with genotype A in Canada, Journal of General Virology, 2008, 89, 12, 3009

    CrossRef

  45. 45
    F. Blaine Hollinger, Hepatitis B virus infection and transfusion medicine: science and the occult, Transfusion, 2008, 48, 5
  46. 46
    George V. Papatheodoridis, Emanuel K. Manesis, Spilios Manolakopoulos, Ioannis S. Elefsiniotis, John Goulis, John Giannousis, Antonios Bilalis, Georgia Kafiri, Dimitrios Tzourmakliotis, Athanasios J. Archimandritis, Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection?, Hepatology, 2008, 48, 5
  47. 47
    G. V. Papatheodoridis, N. Chrysanthos, E. Hadziyannis, E. Cholongitas, E. K. Manesis, Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection, Journal of Viral Hepatitis, 2008, 15, 6
  48. 48
    D. Scott Bowden, Alex J. Thompson, New developments in HBV molecular diagnostics and quantitative serology, Hepatology International, 2008, 2, S1, 3

    CrossRef

  49. 49
    Corinna M. Leistner, Stefanie Gruen-Bernhard, Dieter Glebe, Role of glycosaminoglycans for binding and infection of hepatitis B virus, Cellular Microbiology, 2008, 10, 1
  50. 50
    Jean–Michel Pawlotsky, Geoffrey Dusheiko, Angelos Hatzakis, Daryl Lau, George Lau, T. Jake Liang, Stephen Locarnini, Paul Martin, Douglas D. Richman, Fabien Zoulim, Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach, Gastroenterology, 2008, 134, 2, 405

    CrossRef

  51. 51
    Claudio Galli, Elisa Orlandini, Luigi Penzo, Renzo Badiale, Giacomo Caltran, Sara Valverde, Gianluca Gessoni, What is the role of serology for the study of chronic hepatitis B virus infection in the age of molecular biology?, Journal of Medical Virology, 2008, 80, 6
  52. 52
    Claire Fournier, Fabien Zoulim, Antiviral Therapy of Chronic Hepatitis B: Prevention of Drug Resistance, Clinics in Liver Disease, 2007, 11, 4, 869

    CrossRef

  53. 53
    J Saldanha, M Silvy, N Beaufils, R Arlinghaus, G Barbany, S Branford, J-M Cayuela, G Cazzaniga, M Gonzalez, D Grimwade, V Kairisto, K Miyamura, M Lawler, T Lion, E Macintyre, F-X Mahon, M C Muller, M Ostergaard, H Pfeifer, G Saglio, C Sawyers, O Spinelli, V H J van der Velden, J Q Wang, K Zoi, V Patel, P Phillips, P Matejtschuk, J Gabert, Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements, Leukemia, 2007, 21, 7, 1481

    CrossRef

  54. 54
    Angelo R. Margaritis, Stewart M. Brown, Clive R. Seed, Philip Kiely, Bruno D'Agostino, Anthony J. Keller, Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA, Transfusion, 2007, 47, 10
  55. 55
    J.-F. CADRANEL, P. LAHMEK, X. CAUSSE, G. BELLAICHE, L. BETTAN, T. FONTANGES, A. MEDINI, J. HENRION, M. CHOUSTERMAN, B. CONDAT, P. HERVIO, P. PERIAC, C. EUGÈNE, H. MOINDROT, D. GRASSET, O. NOUEL, C. PILETTE, N. SZOSTAK-TALBODEC, J.-M. CAYLA, S. N. SI-AHMED, P. DUMOUCHEL, A. PARIENTE, B. LESGOURGUES, J. DENIS, Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis – results of a nationwide survey, Alimentary Pharmacology & Therapeutics, 2007, 26, 4
  56. 56
    Hyung Joon Yim, Kwan Soo Byun, Yun Jung Chang, Yeon Seok Suh, Jong Eun Yeon, Chang Hong Lee, Jung Ah Kwon, Wangdon Yoo, Soo-Ok Kim, Sun Pyo Hong, Levels of Hepatitis B Virus (HBV) Replication During the Nonreplicative Phase: HBV Quantification by Real-Time PCR in Korea, Digestive Diseases and Sciences, 2007, 52, 9, 2403

    CrossRef

  57. 57
    Kwan Sik Lee, Dong Joon Kim, Management of Chronic Hepatitis B, The Korean Journal of Hepatology, 2007, 13, 4, 447

    CrossRef

  58. 58
    A. Mühlbacher, B. Weber, P. Bürgisser, A. Eiras, J. Cabrera, S. Louisirirotchanakul, F.-W. Tiller, H.-S. Kim, J. v. Helden, V. Bossi, J.-M. Echevarria, Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants, Medical Microbiology and Immunology, 2007, 197, 1, 55

    CrossRef

  59. 59
    On Jeong, Jong-Hyun Kim, The outcome of perinatal prophylaxis for HBeAg positive mothers according to the maternal HBV-DNA levels at the delivery time, Korean Journal of Pediatrics, 2007, 50, 4, 348

    CrossRef

  60. 60
    Geoffrey Dusheiko, Candidates for therapy: HBV, Journal of Hepatology, 2006, 44, S84

    CrossRef

  61. 61
    Jean-Pierre Zarski, Patrick Marcellin, Vincent Leroy, Christian Trepo, Didier Samuel, Nathalie Ganne-Carrie, Karl Barange, Valérie Canva, Michel Doffoel, Paul Cales, Characteristics of patients with chronic hepatitis B in France: Predominant frequency of HBe antigen negative cases, Journal of Hepatology, 2006, 45, 3, 355

    CrossRef

  62. 62
    Robert G. Gish, Stephen A. Locarnini, Chronic Hepatitis B: Current Testing Strategies, Clinical Gastroenterology and Hepatology, 2006, 4, 6, 666

    CrossRef

  63. 63
    Jeong Heo, Won Ook Go, Gwang Ha Kim, Dae Hwan Kang, Geun Am Song, Mong Cho, Hyung Hoi Kim, Eeu Yup Lee, HBV DNA Quantitation Using Real-time PCR, The Korean Journal of Laboratory Medicine, 2006, 26, 6, 424

    CrossRef

  64. 64
    Angelos Hatzakis, Emmanouil Magiorkinis, Catherine Haida, HBV virological assessment, Journal of Hepatology, 2006, 44, S71

    CrossRef

  65. 65
    L. Comanor, P. Holland, Hepatitis B virus blood screening: unfinished agendas, Vox Sanguinis, 2006, 91, 1
  66. 66
    F. Blaine Hollinger, Daryl T.-Y. Lau, Hepatitis B: The Pathway to Recovery Through Treatment, Gastroenterology Clinics of North America, 2006, 35, 2, 425

    CrossRef

  67. 67
    F. Blaine Hollinger, Daryl T.-Y. Lau, Hepatitis B: The Pathway to Recovery Through Treatment, Gastroenterology Clinics of North America, 2006, 35, 4, 895

    CrossRef

  68. 68
    Yoon-Seon Lee, Dong Jin Suh, Young-Suk Lim, Suk Won Jung, Kang Mo Kim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Wangdon Yoo, Soo-Ok Kim, Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy, Hepatology, 2006, 43, 6
  69. 69
    Mary C. Kuhns, Michael P. Busch, New Strategies for Blood Donor Screening for Hepatitis B Virus, Molecular Diagnosis & Therapy, 2006, 10, 2, 77

    CrossRef

  70. 70
    Chu Chieh Hsia, Robert H. Purcell, Mahmood Farshid, Peter A. Lachenbruch, Mei-ying W. Yu, Quantification of hepatitis B virus genomes and infectivity in human serum samples, Transfusion, 2006, 46, 10
  71. 71
    Julie C. Servoss, Lawrence S. Friedman, Serologic and Molecular Diagnosis of Hepatitis B Virus, Infectious Disease Clinics of North America, 2006, 20, 1, 47

    CrossRef

  72. 72
    Paul J. Payette, Xiaoying Ma, Risini D. Weeratna, Michael J. McCluskie, Max Shapiro, Ron E. Engle, Heather L. Davis, Robert H. Purcell, Testing of CpG-Optimized Protein and DNA Vaccines against the Hepatitis B Virus in Chimpanzees for Immunogenicity and Protection from Challenge, Intervirology, 2006, 49, 3, 144

    CrossRef

  73. 73
    Vicente Carreño, Javier Bartolomé, Inmaculada Castillo, Congenital and Other Related Infectious Diseases of the Newborn, 2006,

    CrossRef

  74. 74
    J. Saldanha, A. Heath, N. Lelie, G. Pisani, M.-Y. Yu, A World Health Organization International Standard for hepatitis A virus RNA nucleic acid amplification technology assays, Vox Sanguinis, 2005, 89, 1
  75. 75
    Mohsin Raza, Collaborative healthcare research: Some ethical considerations, Science and Engineering Ethics, 2005, 11, 2, 177

    CrossRef

  76. 76
    Harald H Kessler, Comparison of currently available assays for detection of hepatitis B virus DNA in the routine diagnostic laboratory, Expert Review of Molecular Diagnostics, 2005, 5, 4, 531

    CrossRef

  77. 77
    Robert G. Gish, Current Treatment and Future Directions in the Management of Chronic Hepatitis B Viral Infection, Clinics in Liver Disease, 2005, 9, 4, 541

    CrossRef

  78. 78
    Willi K. Roth, Empfehlungen zur qualitätsgesicherten Durchführung von Nukleinsäure-Amplifikations - Testungen (NAT) von Blutprodukten. Quality assurance in nucleic acid amplification testing (NAT) of blood products, LaboratoriumsMedizin, 2005, 29, 2

    CrossRef

  79. 79
    Kang Cai, Todd M Gierman, JoAnn Hotta, Christopher J Stenland, Douglas C Lee, Dominique Y Pifat, Steve R Petteway, Ensuring the Biologic Safety of Plasma-Derived Therapeutic Proteins, BioDrugs, 2005, 19, 2, 79

    CrossRef

  80. 80
    M. H. G. M. Koppelman, M. C. Sjerps, H. W. Reesink, H. T. M. Cuypers, Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection, Vox Sanguinis, 2005, 89, 4
  81. 81
    Bernard Weber, Annemarie Berger, Molecular detection of hepatitis B virus: recent developments. Molekularer Nachweis des Hepatitis B-Virus: Aktueller Entwicklungsstand, LaboratoriumsMedizin, 2005, 29, 1, 33

    CrossRef

  82. 82
    Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Molecular virology and drug resistance in antiviral therapy of chronic hepatitis B, Current Hepatitis Reports, 2005, 4, 1, 27

    CrossRef

  83. 83
    Marco H.G.M. Koppelman, Azzedine Assal, Michael Chudy, Pilar Torres, R. Garcia De Villaescusa, Henk W. Reesink, P. Nico Lelie, H. Theo M. Cuypers, Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations, Transfusion, 2005, 45, 8
  84. 84
    G. Gessoni, P. Barin, G. Marchiori, G. Pisani, G. Gentili, F. Bressan, G. Aprili, Nucleic acid amplification technology screening for HBV DNA in Italy: routine application. Report on the first HBV DNA-positive HBsAG-negative donor, Transfusion Medicine, 2005, 15, 3
  85. 85
    J.A. Garson, P.R. Grant, U. Ayliffe, R.B. Ferns, R.S. Tedder, Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control, Journal of Virological Methods, 2005, 126, 1-2, 207

    CrossRef

  86. 86
    Bernard Weber, Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene, Expert Review of Molecular Diagnostics, 2005, 5, 1, 75

    CrossRef

  87. 87
    Perrine Caillet-Fauquet, Mario Di Giambattista, Marie-Louise Draps, Flavienne Sandras, Theo Branckaert, Yvan de Launoit, Ruth Laub, Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19, Journal of Virological Methods, 2004, 118, 2, 131

    CrossRef

  88. 88
    Shahika Aytay, Asa Ohagen, Michael P. Busch, Bernadette Alford, John R. Chapman, Aris Lazo, Development of a sensitive PCR inhibition method to demonstrate HBV nucleic acid inactivation, Transfusion, 2004, 44, 4
  89. 89
    P. Caillet-Fauquet, M-L. Draps, M. Di Giambattista, Y de Launoit, Ruth Laub, Hypoxia enables B19 erythrovirus to yield abundant infectious progeny in a pluripotent erythroid cell line, Journal of Virological Methods, 2004, 121, 2, 145

    CrossRef

  90. 90
    H. G. M. Niesters, Molecular and diagnostic clinical virology in real time, Clinical Microbiology and Infection, 2004, 10, 1
  91. 91
    SCOTT BOWDEN, New directions in molecular diagnostics for hepatitis B: serum and tissue-based diagnostics, Journal of Gastroenterology and Hepatology, 2004, 19,
  92. 92
    Sani Hussein Aliyu, Muktar Hassan Aliyu, Hamisu M Salihu, Surendra Parmar, Hamid Jalal, Martin David Curran, Rapid detection and quantitation of hepatitis B virus DNA by real-time PCR using a new fluorescent (FRET) detection system, Journal of Clinical Virology, 2004, 30, 2, 191

    CrossRef

  93. 93
    Julie C Servoss, Lawrence S Friedman, Serologic and molecular diagnosis of hepatitis B virus, Clinics in Liver Disease, 2004, 8, 2, 267

    CrossRef

  94. 94
    Hubert G.M. Niesters, Elisabeth Puchhammer-Stöckl, Standardisation and controls, why can’t we overcome the hurdles?, Journal of Clinical Virology, 2004, 31, 2, 81

    CrossRef

  95. 95
    Annemarie Berger, Encyclopedia of Medical Genomics and Proteomics, 2004,

    CrossRef

  96. 96
    R. Stefan Ross, Encyclopedia of Medical Genomics and Proteomics, 2004,

    CrossRef

  97. 97
    J. Saldanha, A. Heath, Collaborative study to calibrate hepatitis C virus genotypes 2–6 against the HCV International Standard, 96/790 (genotype 1), Vox Sanguinis, 2003, 84, 1
  98. 98
    Robin Biswas, Edward Tabor, Chu Chieh Hsia, David J. Wright, Megan E. Laycock, Eberhard W. Fiebig, Lorraine Peddada, Richard Smith, George B. Schreiber, Jay S. Epstein, George J. Nemo, Michael P. Busch, Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection, Transfusion, 2003, 43, 6
  99. 99
    Erwin Sablon, Fred Shapiro, Fabien Zoulim, Early detection of hepatitis B drug resistance: implications for patient management, Expert Review of Molecular Diagnostics, 2003, 3, 5, 535

    CrossRef

  100. 100
    Michael Roggendorf, Sergei Viazov, Health care workers and hepatitis B, Journal of Hepatology, 2003, 39, 89

    CrossRef

  101. 101
    Jean-Michel Pawlotsky, Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics, Journal of Hepatology, 2003, 39, 31

    CrossRef

  102. 102
    Hubert G.M Niesters, Clinical virology in real time, Journal of Clinical Virology, 2002, 25, 3

    CrossRef

  103. 103
    J. Saldanha, N. Lelie, M. W. Yu, A. Heath, Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques, Vox Sanguinis, 2002, 82, 1
  104. 104
    Jean–Michel Pawlotsky, Molecular diagnosis of viral hepatitis, Gastroenterology, 2002, 122, 6, 1554

    CrossRef

  105. 105
    Edward Tabor, Jay S. Epstein, NAT screening of blood and plasma donations: evolution of technology and regulatory policy, Transfusion, 2002, 42, 9
  106. 106
    P. R. Grant, M. P. Busch, Nucleic acid amplification technology methods used in blood donor screening, Transfusion Medicine, 2002, 12, 4
  107. 107
    P. Nico Lelie, Harry A.J. Van Drimmelen, H. Theo M. Cuypers, Susan J. Best, Susan L. Stramer, Catherine Hyland, Jean-Pierre Allain, Pierre Moncharmont, Christine Defer, Micha Nübling, Andreas Glauser, Marcia Da Silva Cardoso, Jean-François Viret, Mervi H. Lankinen, Lena Grillner, Urs Wirthmüller, Joliette Coste, Volkmar Schottstedt, Barbara Masecar, Elizabeth M. Dax, Sensitivity of HCV RNA and HIV RNA blood screening assays, Transfusion, 2002, 42, 5
  108. 108
    Shaffer Mok, Sachin Mohan, Krystal M Hunter, Yize R Wang, Thomas A Judge, Adefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infection, The Cochrane Library,
  109. 109
    Anat Fisher, Vijaya M Musini, Ken Bassett, Antiviral treatments for lamivudine-resistant chronic hepatitis B adult patients, The Cochrane Library,
  110. 110
    Wolfram H. Gerlich, Michael Kann, Hepatitis B, Topley and Wilson's Microbiology and Microbial Infections,
  111. 111
    Khalid Mumtaz, Umair Syed Ahmed, Nadeem F Zuberi, Sumaira Salamat, Wasim Jafri, Lamivudine during pregnancy for preventing hepatitis B virus infection in newborns, The Cochrane Library,
  112. 112
    Khalid Mumtaz, Amna Subhan, Saeed Hamid, Wasim Jafri, Lamivudine for chronic hepatitis B in adults, The Cochrane Library,